Viewing Study NCT00854867

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:55 AM
Ignite Modification Date: 2026-06-28 @ 9:25 PM
Study NCT ID: NCT00854867
Status: COMPLETED
Last Update Posted: 2014-02-24
First Post: 2009-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.
Sponsor: Mundipharma Research Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumour Neoplastic Meningitis View
None Brain Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DepoCyte View
None WBRT View
None Whole Brain Radiotherapy View
None Liposomal cytarabine intrathecal View
None Solid Tumour Neoplastic Meningitis with or without brain metastasis View
None Solid tumour neoplastic meningitis View
None STNM View
None leptomeningeal metastases View